All Stories

  1. Progressive spinal cord involvement in Leigh syndrome due to an NDUFV1 variant
  2. The Rate of Covid-19 Positivity Should not be Calculated on the Basis of Self-Reporting in Questionnaires
  3. Venous Sinus Thrombosis in High-Risk Patients Should Not be Misinterpreted as Conversion Disorder
  4. Vestibular Migraine or Transitory Ischemic Attack in the Posterior Circulation: How to Differentiate
  5. A Review of Musculoskeletal Disorders Should Also Include Diseases of the Peripheral Nerves and Skeletal Muscles
  6. Metoclopramide, Whether I.M. or I.V., Should Not Be a Panacea for Primary Headaches in Emergency Departments
  7. Whether Risk Reduction of Strokes by Tofu is Possible Remains Uncertain as Long as it is not Evaluated as a Heterogeneous Nutrient
  8. Leigh Syndrome Due to the Variant c.1019T>C in COX15
  9. Are Insulin and Metformin Really Protective on Amyotrophic Lateral Sclerosis by Blocking the Astrocytic Cx43 Channel?
  10. Pseudo‐Schizophrenia Should Always Be Considered in Genetic Studies Regarding Psychosis
  11. All Influencing Factors Should Be Taken into Account When Calculating Outcome Predictors for Paediatric Status Epilepticus [Letter]
  12. Before diagnosing stroke-like episodes in OPA1-related mitochondrial disorder, its imaging criteria must be met
  13. Hypokalemic Periodic Paralysis Can Be Attributed to Exogenous Hyperthyroidism Only After Exclusion of All Primary and Secondary Causes
  14. The Degree to Which Outcomes in Out-of-Hospital Cardiac Arrest Depend on the Quality of Mobile ICUs Requires Appropriately Designed Studies
  15. The Glycaemic Gap is not a Reliable Prognostic Biomarker for Predicting Post-Stroke Cognitive Impairment [Letter]
  16. Neuroimaging in Mitochondrial Encephalomyopathy with Lactic Acidosis with Stroke-Like Episodes (MELAS): Correspondence
  17. Before HSP40 Polymorphisms Are Held Responsible for an Increased Stroke Risk, All Other Influencing Factors Must Be Excluded
  18. Commentary on: Sağlam İ, Aslan R, Akgür SA, Kurtulmuş Y. Abuse of gabapentinoids in individuals with substance use disorders. J Forensic Sci. 2025;70(3):1125–32. doi: 10.1111/1556‐4029.70028
  19. Syphilitic Myelitis is not Rare and is Usually Associated with Cerebral Manifestations of the Infection
  20. Appropriately designed studies are required to assess sleep quality in epilepsy patients
  21. Recurrent polychondritis associated with rheumatoid arthritis and ataxia unresponsive to TNF-alpha blockers and JAK inhibitors
  22. The Presence of the mtDNA4977 Deletion Does Not Necessarily Mean That It is Responsible for Major Depression [Letter]
  23. The spectrum of ophthalmologic abnormalities in MELAS is broader than expected
  24. All Factors Influencing Microstate Changes in Stroke Patients must be Taken into Account before the Stroke is Blamed as the Only Determinant
  25. Comment on ‘Quantification of Skeletal Muscle at the First Lumbar Level for Prognosis in Amyotrophic Lateral Sclerosis’ by Cao et al.
  26. COVID‐19 Patients With Neurological Symptoms Require a Neurological Diagnosis and the Establishment of a Causal Relationship
  27. Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account
  28. El espectro de anomalías oftalmológicas en MELAS es más amplio de lo esperado
  29. Before scoliosis can be attributed to the variant c.326G>A in MYH3, its pathogenicity must be proven
  30. Whether the Opsoclonus Myoclonus Syndrome Is Paraneoplastic or SARS‐CoV‐2–Related Can Be Clarified
  31. Schizophrenia and schizoaffective are useful terms of essential concepts in medicine: what we need is a general consideration and more research regarding the causes of secondary psychotic syndromes
  32. Letter to the Editor From Finsterer “Diverse Phenotypes of Mitochondrial Disease With Varying Levels of Heteroplasmy”
  33. Less Social Contact During the Pandemic Could Explain the Lower Prevalence of GBS During This Time
  34. Clinico-Radiological and Genotypic Spectrum of Nuclear Mitochondriopathies: Correspondence
  35. The Salt & Pepper Enigma: A Cutaneous Cipher to Seronegative Systemic Sclerosis with Myopathy – Correspondence
  36. Aflibercept for the treatment of pigmentary retinopathy in Kearns-Sayre syndrome?
  37. Axonal Neuropathy in Hepatic Porphyria Should Not be Confused With Guillain-Barre Syndrome
  38. The EEG is Not Suitable for Diagnosing Delirium, But Can Exclude Epileptic Activity as a Cause
  39. Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out
  40. Insomnia due to a dislocation storm in hypermobile Ehlers-Danlos syndrome with small fibre neuropathy and recurrent syncope
  41. Polyendocrinopathy and multisystem involvement are common phenotypic features of Kearns-Sayre syndrome
  42. Nature’s Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson’s Disease
  43. Before sudden death can be attributed to bilateral pneumothorax due to a COL3A1 mutation, its pathogenicity must be proven
  44. Before stress symptoms, anxiety and depression can be attributed to a SARS-CoV-2 infection, alternative causes must be ruled out
  45. Handgrip strength of skiers is not an ideal biomarker of a person’s fitness
  46. Before executive dysfunction is attributed to fibromyalgia, other causes must be thoroughly ruled out
  47. Homogeneous ALS Cohorts in Terms of Etiology, onset type, and Vaccination Status Are Required to Assess the Outcome of Their COVID Infection
  48. Autonomic Complications of Seizures and Migraines
  49. Until all differential causes have been ruled out, aortic dissection should not be associated with chronic cocaine use
  50. Even if a genetic autopsy reveals a pathogenic variant, this should not prevent forensic experts from looking for other causes
  51. Before a Diagnosis of Schizophreniform Disorder is Made, All Causes of Secondary Psychosis Should Be Ruled Out
  52. Before Trapezius RNS Can Be Recommended as an Additional Tool for the Diagnosis of ALS, Well-Powered Prospective Studies Are Required
  53. Regardless of the genotype, Leigh syndrome requires comprehensive work-up for clinical or subclinical multisystem involvement
  54. The Spectrum of Risk Factors for Falls is Broader Than Expected
  55. Comment on Chanoine et al. Is Hyperactive mTORC1 Signaling Responsible for the Phenotypic Expression (Diabetes, Hypoacusis) of the m.3243A>G Variant?
  56. Correlation between Post-Traumatic Stress Disorder and SARS-CoV-2 Infection
  57. Death in the mountains requires extensive forensic considerations and investigations
  58. Previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS
  59. Coffee and tea are unlikely to be risk factors or preventers of Alzheimer's disease or vascular dementia
  60. Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
  61. Gray-to-White Matter Ratio May Be Inadequate to Assess the Neurological Outcome of Patients with Hypoxic Brain Damage Due to Cardiac Arrest
  62. Handgrip strength is probably not a predictor of mortality in patients with cardiovascular disease
  63. Neurological side effects of SARS-CoV-2 vaccination are common and can be severe
  64. Pitfalls in Calculating the Incidence of Guillain‐Barre Syndrome During the Pandemic
  65. The Incidence of Delayed Intracerebral Hemorrhage After Head Trauma Under Anticoagulation Can Depend Strongly on the Quality of Anticoagulation
  66. To identify long-term antiretroviral therapy as the cause of secondary mitochondrial disease, comprehensive investigations are required
  67. Pembrolizumab‐Induced Secondary Hypocorticism Manifesting as a Transitory Ischemic Attack
  68. Proximal Muscle Weakness in a Toddler Due to Vitamin D Deficiency Rickets: Correspondence
  69. Identification of Biomarkers of Arrhythmogenic Cardiomyopathy (ACM) by Plasma Proteomics
  70. To: Efficacy of melatonin in decreasing the incidence of delirium in critically ill adults: a randomized controlled trial
  71. To: Prognostic significance of gastrointestinal dysfunction in critically ill patients with COVID-19
  72. To: Delirium and sleep quality in the intensive care unit: the role of melatonin
  73. To: Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients
  74. Aseptic thoracic spondylodiscitis (pseudo discitis) in a septuagenarian without predisposing factors
  75. Before a fluctuating unilateral ptosis can be attributed to ipsilateral midbrain stroke, alternative etiologies must be thoroughly excluded
  76. Cortical atrophy is a common phenotypic feature in MELAS patients
  77. Fatal long-term complications due to bendamustine for Waldenstrom's macroglobulinemia
  78. Hearing loss and small and large fibre neuropathy associated with the heterozygous variants c.20A>T in HBB and del-3.7 in HBA
  79. New, late-onset relapsing-remitting multiple sclerosis in a woman in her 60s after SARS-CoV-2 vaccination
  80. Small fiber neuropathy with dysautonomia and positive GPCR and FGFR-3 antibodies after the first BNT162b2 dose
  81. The new variant c.458C>G in CHRNA1 causes late-onset post-synaptic slow-channel congenital myasthenic syndrome
  82. mtDNA deletion m.8753_16566 with < 10 % heteroplasmy in muscle and isolated complex-V dysfunction misinterpreted as chronic fatigue syndrome over 21-years
  83. Appropriately designed studies are required before valproic acid, carbamazepine, and oxcarbazepine can be blamed for thyroid dysfunction
  84. Before attributing improved sleep quality to an anti-inflammatory diet, alternative causes must be ruled out
  85. Before respiratory muscle weakness is attributed to a stroke, alternative causes must be considered and thoroughly ruled out
  86. Comments on: “Stroke-Like Episode, Aphasia, and Hearing Loss in MELAS”
  87. Determining Whether the Glymphatic System is Truly Impaired in Pediatric Patients With Refractory Epilepsy Requires Appropriately Designed Studies
  88. Food, Water, Air, and Mind must Become Cleaner
  89. In Vitro and In Vivo Models of Neuroschistosomiasis
  90. It is unlikely that major depression severity correlates with white matter lesion volume
  91. Letter to the Editor: Limitations of the MMSE in the Diagnosis and Staging of Dementia: A Commentary
  92. MRI Morphometry of the Spinal Cord Depends on Several Factors That Must Be Taken Into Account When Selecting Healthy Volunteers
  93. Sleep deprivation in third-trimester pregnancies is multi-causal and requires careful differential consideration
  94. Sophisticated prospective studies are needed to evaluate the relationship between chronic neck pain and autonomic function
  95. The reliability of the mini mental state examination and Montreal Cognitive Assessment for assessing cognitive impairment also depends on the type of cognitive deficits
  96. The worsening of low back pain in teachers during the pandemic is multicausal and not only due to social environment and working conditions
  97. Schizophrenia misdiagnosis after dysmorphophobia in a patient with macrocephaly
  98. Are stroke-like events in pyruvate dehydrogenase deficiency ischemic, metabolic, or both in nature?
  99. Unimpaired vision is an indispensable prerequisite for safe driving
  100. Clarification of Symptoms in an Emergency Department Must Be Sufficient to Prevent Early Death After Discharge
  101. Is transcranial direct current stimulation really beneficial for frontotemporal dementia?
  102. Poor outcome of non-isolated noncompaction (LVNC) suggests that additional heart disease, not LVNC, is responsible
  103. Chikungunya-related Guillain-Barre syndrome is most commonly demyelinating and affects multiple cranial nerves
  104. New-born Screening for Mitochondrial Disorders is Useful for Genetic Counseling and Early Treatment when Available
  105. Letter re: Aseptic pleocytosis can only be classified as a phenotypic manifestation of MNGIE after exclusion of all differential causes
  106. Before the variant c.541A>G in UGT1A6 can be held responsible for valproate-induced tremor, alternative causes must be ruled out
  107. Predictors of in-hospital mortality after thrombolysis of ischemic stroke should not be limited to a single ratio of red blood cell parameters
  108. Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics
  109. Before a focal status epilepticus is held responsible for triggering Takotsubo in multiple sclerosis, alternative pathophysiologies must be ruled out
  110. The diagnosis of Creutzfeldt–Jakob disease in a SARS-CoV-2-infected patient should be confirmed by brain biopsy or autopsy
  111. Simultaneous Juvenile Stroke and Myocardial Infarction Require Clarification of the Underlying Etiology and Adequate Treatment
  112. The quality of sleep in systemic sclerosis patients is determined not only by the underlying disease but also by many internal and external factors
  113. Carriers of the m.3243A>G variant should not be labelled with an acronym before they have been systematically screened for multisystem disease
  114. Syncope in Kearns–Sayre syndrome may not only be due to AV-block, but may also have other causes due to the multiorgan nature of the disease
  115. Before leg pain and paraparesis are attributed to vitamin C deficiency alone, comorbidities and cocausalities must be considered and ruled out
  116. An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
  117. Comments on “The Use of tDCS in a Patient with MECP2 Gene Mutation Presenting with Recurrent Catatonia: A Case Report”
  118. Correspondence
  119. Correspondence
  120. Post‐COVID dysphagia requires exclusion of SARS‐CoV‐2–associated brainstem encephalitis, vasculitis, polyneuritis cranialis, and myositis
  121. To prevent sudden death in m.3243A>G carriers, comprehensive neurologic, cardiac, and pulmological examinations are required
  122. Unexpected death in alcohol addiction requires extensive post-mortem assessment
  123. Whether tamoxifen is beneficial for cardiac dysfunction in Duchenne muscular dystrophy requires appropriately designed studies
  124. Comments on “Reversal of Abulia with Atomoxetine in Unilateral Basal Ganglia Infarct: A Case Report”
  125. A Relapse of Restless Leg Syndrome Due to COVID-19 Can Only Be Diagnosed If Other Explanations Are Ruled Out
  126. Before Gastrointestinal Symptoms in Students Can Be Attributed to Anxiety and Depression during the Lockdown, Alternative Causes Must Be Ruled Out [Letter]
  127. Cluster Analysis to Specify the MELAS Genotype and Phenotype Must Consider Genetic Background Peculiarities and Disease Progression
  128. El riesgo de hipertermia maligna es bajo en casos de neuromiotonía
  129. Elevated C-reactive protein and IL-6 signalling are not the only determinants of sleep quality and duration
  130. In order to reliably assess nurses’ optimism, resilience and experience during the pandemic, all influencing factors must be taken into account
  131. Prehospital Spinal Muscle Mass Is Unlikely to Be a Predictor of COVID-19 Mortality
  132. The risk of malignant hyperthermia in neuromyotonia is low
  133. MIDD Patients Should Not Be Confused with MELAS Patients, Even Though Both Carry the m.3243A>G Variant
  134. Before Low Serum Cortisol Can Be Attributed to SARS-Cov-2 Infection, Alternative Causes Must Be Ruled Out
  135. There are several differential diagnoses for SARS-CoV-2-related myelitis
  136. Letter to the editor: before molecules are claimed as biomarkers of COVID-19, their criteria must be met
  137. Diagnosing functional seizures with a single video-EEG may miss epileptic seizures
  138. Diagnostic accuracy is required when analysing cohorts with mitochondrial disorders
  139. Mitochondrial Diabetes May Not Be the Only Phenotypic Presentation of the m.5826A>G mtDNA Variant [Letter]
  140. Neurological complications of SARS-CoV-2 infection in children can be acute or post-acute
  141. Erdheim-Chester disease requires extensive prospective and thorough work-up for multisystem involvement
  142. Re: ‘Vagus nerve dysfunction in the post-COVID-19 condition’ by Lladós et al.
  143. Crime rates in Wernicke-Korsakoff syndrome and alcohol-related dementia may not depend solely on these disorders
  144. HMGCR-associated myopathy in polymorbid patients with polypharmacy should not be attributed solely to statins
  145. Gastrointestinal involvement in neuromuscular disorders
  146. Post-COVID depression and anxiety are multicausal and not necessarily due to SARS-CoV-2 infection
  147. Antes de culpar a la cirugía lumbar de un neumoencéfalo deben descartarse completamente las causas alternativas
  148. Before lumbar surgery is blamed for pneumocephalus, alternative causes must be thoroughly ruled out
  149. When calculating COVID-19 incidence, mandatory PCR testing should be preferred over voluntary antigen testing
  150. Before Diagnosing SARS-CoV-2 Vaccination-Associated Immune Encephalitis Alternative Aetiologies Must Be Ruled Out
  151. Prevalence of Sensory Processing Deficits in Children with Spastic Cerebral Palsy - An Indian Caregiver’s Perspective: Correspondence
  152. Recurrent Mononeuropathy, Stroke and Deafness in a Teenage Boy: Correspondence
  153. All available diagnostic and therapeutic options should be fully exploited in order to quickly identify and optimally treat neuropathic pain in long-COVID
  154. Antes de diagnosticarse PRES relacionada con SARS-CoV-2 deben descartarse diagnósticos alternativos
  155. Antibody responses to SARS-CoV-2 vaccines in neuromuscular disorders may depend on their etiology and current drug treatment
  156. Before attributing impaired cognition in the elderly to COVID-19, all influencing factors must be considered
  157. Before diagnosing a SARS-CoV-2-related PRES, alternative diagnoses must be ruled out
  158. Calculate incidence rates of BNT162b2-related arterial or venous thrombosis only from the entire cohort of interest
  159. Comments on “Social networkassociated with depressed mood andsarcopenia among older adults in Taiwan”
  160. Mitochondrial diabetes plus phenotypes due to the m.3243A > G variant require correlation with heteroplasmy rates
  161. Neurogenesis and pesticides: news of no new neurons
  162. Neurological complications of COVID-19 in pediatric patients require comprehensive diagnostic workup
  163. No Venlafaxine Intoxication is Required, Epileptic Seizures Alone Prolong QRS and QTC
  164. To the Editor—Small fiber neuropathy is responsible for POTS in SARS-CoV-2 vaccines
  165. Vanishing white matter in multiple mitochondrial dysfunction syndrome-2 due to compound heterozygosity for novel BOLA3 variants
  166. Whether Inspiratory Muscle Training Really Makes Sense in Myotonic Dystrophy Requires Appropriately Designed Trials
  167. Assessing a potential therapeutic effect of cannabidiol for lower back pain, requires appropriately designed studies
  168. Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic
  169. Serum and CSF cytokine profiles in SARS-CoV-2-associated polyradiculitis depend on many influencing factors
  170. Letter to the Editor From J. Finsterer: “Explaining Long COVID: A Pioneer Cross-Sectional Study Supporting the Endocrine Hypothesis”
  171. Brain Temperature, Choline, N-Acetyl-Aspartate, and Myo-Inositol Measured by MRS Can Only Be Considered Diagnostic Biomarkers if Their Criteria are Met [Letter]
  172. MPV17-related mtDNA depletion syndrome complicated by postreperfusion syndrome during liver transplantation
  173. The pathogenicity of variant c.597dup in SLC19A3 and treatability of its phenotype remain unconfirmed
  174. Whole exome sequencing is the method of choice to determine the etiology of developmental epileptic encephalopathy
  175. Frequency, Severity, Risk Factors, and Outcome of Hemorrhagic Transformation in Anterior and Posterior Stroke
  176. Amyotrophic Lateral Sclerosis due to ALS2 Pathogenic Variant Masquerading as Cerebral Palsy: Correspondence
  177. Neurological complications of a SARS-CoV-2 infection require a thorough and comprehensive evaluation
  178. Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome – Correspondence
  179. Commentary on: Reduced physical activity level was associated with poorer quality of life during the early phase of the COVID-19 pandemic: a sub-study of the last-long trial
  180. Before blaming metformin as a trigger for stroke-like lesions in MELAS, alternative etiologies must be off the table
  181. Recurrent transitory attacks with cytotoxic edema could benefit from thrombolysis
  182. Alternative etiologies of rhabdomyolysis must be ruled out before attributing it to bedding during surgery
  183. Before Hemichorea Can Be Attributed to Diabetic Striatopathy, All Other Causes Must Be Thoroughly Ruled Out
  184. Multilocular DWI-Hyperintense Cerebral Lesions in a Child with Mild Head Trauma Suggest Embolism Rather Than Thrombosis
  185. Normality of morphometric brainstem parameters is highly dependent on comorbidity, skull dimensions, observer bias, and MRI technology
  186. Exploring the Prospective Role of Propolis in Modifying Aging Hallmarks
  187. The More Intensive the Diagnostic Workup, the More Likely It Is That the Cause of Coccygodynia Can Be Clarified
  188. Stress and musculoskeletal pain in physiotherapists during the pandemic depend on a plethora of influencing factors
  189. Before homozygous NDUFAF5 variants are held responsible for intrauterine death, their pathogenicity must be demonstrated
  190. The musculoskeletal manifestations of SARS-CoV-2 infections/vaccinations are more diverse than expected
  191. In patients with neurological complications, SARS-CoV-2 infection must be confirmed by PCR
  192. Rhabdomyolysis triggered by azithromycin
  193. SARS-CoV-2-related polyradiculitis during pregnancy
  194. Molybdenum Cofactor Deficiency (MoCD) Masquerading as Stroke-Like Episodes: Correspondence
  195. Acute messenger RNA-based SARS-CoV-2 vaccine–related meningitis/encephalitis is not uncommon
  196. Assessing the effect of oral glutamine on the MELAS phenotype requires appropriate study designs
  197. Cerebrospinal Fluid Leucine Rich Alpha-2 Glycoprotein in Children with Tubercular Meningitis with their Diagnostic and Prognostic Significance: A Prospective Study: Correspondence
  198. Because secondary intestinal pseudo‐obstruction is potentially treatable, its etiology needs to be clarified
  199. Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
  200. Alternative Causes Must Be Ruled Out Before Meningism Can Be Attributed to Acute Calcific Tendinitis of the Longus Colli Muscle
  201. Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian
  202. Detection of pathogenic mutations in epilepsy-associated genes does not necessarily mean seizures or SUDEP
  203. Increased frequency and intensity of complicated migraine sans migraine after third BNT162b2 dose
  204. Kaposi sarcoma initially manifested itself as blindness
  205. Long-term, unilateral third cranial nerve palsy, ocular myositis, and high CSF interleukine-2 persisting for 14 months after mild SARS-CoV-2 infection-case report
  206. NXP-2 positive dermatomyositis with marked dysphagia following an insect bite
  207. Neurological Symptoms Due To Severe Acute Respiratory Syndrome Coronavirus 2 Infection Require Thorough Evaluation and Assignment to a Diagnosis
  208. Non-functioning pituitary macroadenoma manifesting as a cervical syndrome
  209. Olfactory disorders are a recognised complication of SARS-CoV-2 infections
  210. Sulfasalazine, but not ankylosing spondylitis may be responsible for axonal neuropathy
  211. Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU
  212. Transient, self-limiting, antibody-negative myositis with venetoclax
  213. Water pollution and the brain
  214. What is pesticide-induced epilepsy?
  215. Before Diagnosing CHANTER Syndrome, All Possible Differential Diagnoses Must Be Carefully Excluded
  216. Boswellia serrata intoxication manifesting with syndrome of inappropriate antidiuretic hormone secretion, hyponatremia, seizure, and rhabdomyolysis
  217. Brain Lesions in Liver Cirrhosis May Not Only Be Due to Hepatic Encephalopathy
  218. Cortical Iron Deposition Is Multicausal, and Therefore Cannot Serve as a Biomarker for Early Cognitive Impairment
  219. Depression, anxiety, stress, and well-being in fringe groups
  220. Different Aortic Root Diameters on Echocardiography and MRI During Pregnancy in Mosaic Turner Syndrome
  221. How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated?
  222. Intoxicação por Boswellia serrata manifestando-se com síndrome da secreção inapropriada de hormônio antidiurético, hiponatremia, convulsão e rabdomiólise
  223. Letter to the Editor: Before Characterising Post-Acute Sequelae of SARS-CoV-2 Infection by Viral and Immunologic Parameters, Alternative Causes of Their Increase Must Be Ruled Out
  224. Letter to the Editor: Depending on the Disease Stage and Modifying Factors, mtDNA-Associated Hearing Loss Can Occur With Many mtDNA Mutations
  225. Letter to the Editor: Myocarditis Associated With SARS-CoV-2 Vaccination Diagnosed by Cardiac MRI Requires Confirmation by Endomyocardial Biopsy
  226. Letter to the Editor: SARS-CoV-2-Related Polyradiculitis Requires Exclusion of Alternative Causes and Long-Term Follow-up
  227. Neuromuscular Disorders With Gastrointestinal Tract Affection
  228. Panel testing may not be sufficient to reveal the etiology of suspected genetic epilepsy
  229. Para: Abordagem de cuidados neurocríticos apoiada por monitorização cerebral multimodal após lesão cerebral aguda
  230. Para: Associação entre área de secção transversa do reto femoral e excursão diafragmática com o desmame de pacientes com traqueostomia na unidade de terapia intensiva
  231. Para: Biomarcadores de disfunção neuropsiquiátrica em sobreviventes de unidades de terapia intensiva: um estudo de coorte prospectivo
  232. Para: Desfechos de pacientes gestantes gravemente enfermas com COVID-19: um estudo de coorte
  233. Para: Morte por Staphylococcus aureus comunitário resistente à meticilina: relato de caso
  234. Prevalence of sleep disorders and daytime sleepiness depends on many influencing factors that should be taken into account
  235. Primary Angiitis of the Central Nervous System: Exclusion of Differentials and Long-Term Follow-Up
  236. SARS-CoV-2 Transmission Rate Depends on Infectivity of the Virus Strain, Closeness of Contact, and the Immune Competence of the Infected Person
  237. Side effects of working from home: the dangers affecting the well-being of employees
  238. Sleep quality depends not only on radicular pain but also on other factors
  239. The Glasgow prognosis score is unsuitable for stroke prediction in infectious endocarditis
  240. The anti-infectious effect of antidepressants in psychiatric COVID-19 patients remains unproven
  241. The quality of sleep and digestion in cerebral palsy depends not only on the level of functional independence
  242. The reperfusion rates after recombinant human tissue plasminogen activator thrombolysis depend not on a few but on a plethora of influencing factors
  243. There is currently no evidence that high serum leptin and low insulin-like growth factor-1 levels characterise fibromyalgia
  244. There is no clear epileptic heart syndrome, but there are various cardiac complications following seizures
  245. To: Association between rectus femoris cross-sectional area and diaphragmatic excursion with weaning of tracheostomized patients in the intensive care unit
  246. To: Biomarkers of neuropsychiatric dysfunction in intensive care unit survivors: a prospective cohort study
  247. To: Death by community-based methicillin-resistant Staphylococcus aureus: case report
  248. To: Neurocritical care management supported by multimodal brain monitoring after acute brain injury
  249. To: Outcomes of critically ill pregnant COVID-19 patients: a cohort study
  250. Visually evoked potentials may be abnormal in COVID-19 patients if the infection is complicated by cerebral disease
  251. Connective tissue involvement in an m.10191 T > C carrier with Leigh-like syndrome
  252. MIDD due to variants m.3243A > G or m.12258C > A not necessarily carries an increased risk of obstetric complications
  253. Letter to the Editor regarding Early Diagnosis of Herpes Zoster Neuralgia: A Narrative Review
  254. Comments on “Tako-Tsubo syndrome in patients with COVID-19: a single centre retrospective case series”
  255. Before attributing diastolic dysfunction to basal ganglia bleeding differential etiologies need to be ruled out
  256. Attribute fatal, multiple cavitary lesions with air-fluid levels and hemorraghe to SARS-CoV-2 or ECMO only after ruling out differentials
  257. Before Leigh syndrome can be attributed to m.1608G≥A in MT-TV, its pathogenicity must be confirmed
  258. Adrenal involvement in mitochondrial DNA deletion disorders is highly dependent on comorbidities and pituitary function
  259. Exercise intolerance in post-COVID syndrome cannot only be due to skeletal muscle impairment
  260. Before blaming unilateral upper-limb trauma for cognitive dysfunction, alternative causes must be ruled out
  261. Life but not historical cohorts are required to calculate incidence, severity, and mortality of COVID-19 in epilepsy patients
  262. Multifactorial Dependence of Muscle Relaxant Efficacy in Lower Back Pain
  263. SARS-CoV-2 Vaccination can Only Be Held Responsible for Small Fiber Neuropathy if all Differential Diagnoses Are Excluded
  264. The assessment and interpretation of published data on Guillain–Barre syndrome after SARS‐CoV‐2 vaccination requires care
  265. The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria
  266. Various neurological and non‐neurologic pathophysiological mechanisms can explain SARS‐CoV‐2‐related bilateral vocal cord paralysis
  267. Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment
  268. Diagnosing Leigh syndrome requires typical lesions on cerebral MRI
  269. The Neurovascular Coupling Concept Does Not Sufficiently Explain the Pathophysiology of Stroke‐Like Lesions
  270. Acceleration of sporadic Creutzfeldt–Jakob disease progression by COVID requires evidence from appropriately designed studies
  271. Neuroimaging Abnormalities in Severe Acute Respiratory Syndrome Coronavirus 2 Infected are More Diverse than Previously Thought and Depend on the Methods Used
  272. Re-infections with SARS-CoV-2 require a clarification of favourable risk factors
  273. Sudden unexplained death requires not only search for variants in SUD genes. but also extended autopsy, including the brain
  274. Before juvenile stroke can be attributed to MYH11 variants, alternative etiologies and pathophysiologies must be adequately ruled out
  275. Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance
  276. Respiratory chain defects require prospective work‐up for clinical and subclinical multisystem involvement
  277. SARS-CoV-2 vaccination can only be held responsible for tinnitus after alternative pathophysiology has been ruled out
  278. Sputnik-V side effects can be severe and fatal
  279. The phenotypic heterogeneity of the variant m.5537_5538insT in MT‐TW does not only depend on the heteroplasmy rates
  280. Leigh Syndrome with MT-ND5 Mutation and Hypertrophic Cardiomyopathy: Correspondence
  281. Do not biopsy the MELAS brain
  282. Pure and complex genetic epilepsies with tonic-clonic seizures can be complicated by sudden unexpected death in epilepsy
  283. Seizure phenomenology in MELAS
  284. Sildenafil Intoxication Can Be Complicated by Seizures and an Increase in Creatine Kinase
  285. Stroke‐like lesions should not be mixed up with ischemic stroke in MELAS with cardioembolic risk
  286. The presumed protective effect of IVIG against SARS-CoV-2 in inflammatory myopathy patients remains questionable
  287. Rule out compound heterozygous exonic/deep intronic ABCA4 variants in an MNGIE patient with Stargardt disease
  288. Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
  289. Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
  290. MYH11 mutation carriers manifest not only with an aortic dissection, but also with cerebrovascular, urological, and gastrointestinal disease
  291. Pathogenicity of Variant m.13528A>G in MT-ND5 in Leber’s Hereditary Optic Neuropathy Is Unsupported
  292. Re: “Cardiomyopathy Following Complete Avalanche Burial: A Case Report” by Libersa et al.
  293. Hypophysitis or pituitary apoplexy following a SARS-CoV-2 vaccination
  294. Mitochondrial disorders are not spinocerebellar ataxias but may resemble them in some aspects
  295. Evidence of this speculation is needed before the possible beneficial effect of the ketogenic diet can be attributed to the increase in wild‐type mtDNA
  296. Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study
  297. Stroke‐like episodes and stroke‐like lesions: Two aspects of the same phenomenon
  298. Alternative etiologies must be ruled out before gabapentin withdrawal can be blamed for stroke‐like episodes
  299. Mitochondrial Cardiomyopathy Due to the MT-TI Variant m.4300A>G Requires Comprehensive Clinical and Genetic Workup
  300. A Spinal Tap Does Not Require Skin Marking by Syringe Hickey, Pens, or Fingernails
  301. Before placental damage can be attributed to SARS-CoV-2, alternative causes must be sufficiently ruled out
  302. Hemolytic Anemia Requiring Splenectomy in Leigh-Like Syndrome due to the Variant m.10191T>C in MT-ND3
  303. Metabolic inflexibility and unusual catabolism in Leigh-like syndrome due to m.10191T>C
  304. The nature and severity of SARS-CoV-2 vaccine side effects in athletes are highly dependent on study design
  305. Parkinson’s Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
  306. Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
  307. Prospective studies are required for assessing the outcome of a SARS-CoV-2 infection based on the symptoms at onset
  308. Before an abducens palsy can be attributed to a congenital vitamin-B12 deficiency, alternative causes must be ruled out
  309. Strokelike Episodes in PMM-2 Carriers Differ from Those in Mitochondrial Disorders
  310. Validity of Quantitative, Multi‐Parametric MRI in the Diagnosis of Polyneuropathies
  311. Mitochondrial disorders due to m.3243A>G not meeting diagnostic criteria for MELAS require comprehensive work-up
  312. Before attributing peroneal neuropathy to entrapment, proximal lesions of the ischiadic nerves need to be ruled out
  313. [Artículo traducido] Antes de atribuir la neuropatía peronea al atrapamiento, es necesario descartar lesiones proximales de los nervios isquiádicos
  314. Normal values ​​for ultrasound parameters of the ulnar nerve require homogeneous, healthy cohorts
  315. Anti-mitochondrial antibody–mediated myopathy with cardiac involvement
  316. Confusion in connection with pulmonary hypertension due to premature ventricular complexes requires diagnostic work-up
  317. SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection
  318. Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine model
  319. Acute Fulminant Cerebral Edema Presenting as Refractory Status Epilepticus in a SARS-CoV-2 PCR-Positive Child Without Pulmonary Involvement: Correspondence
  320. Effective treatment of choreaballism due to an MT‐CYB variant with haloperidol, tetrabenazine, and antioxidants
  321. Letter to the Editor regarding “Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes”
  322. Neurological Adverse Reactions to SARS-CoV-2 Vaccines
  323. MTFMT‐Related Leigh Syndrome Phenotypically Manifesting with Mobile Dystonia and Hypoacusis
  324. Before Blaming SARS-CoV-2 for Cerebrovascular Disease in Children, All Differentials Need to Be Ruled Out
  325. Guillain–Barre syndrome with pleocytosis requires workup for cerebral disease
  326. Letter to the Editor Regarding ‘A neonatal case of cerebral venous sinus thrombosis with intrauterine onset after COVID19 infection during pregnancy: cause or coincidence?’
  327. Rule out alternative causes before attributing cerebral hemorrhage to thrombolysis for coronary intervention
  328. SARS-CoV-2 variant-related abnormalities detected by prenatal MRI: direct or indirect effects of the infection must be demonstrated
  329. Needle EMG of the vagus-innervated striated larynx muscles cannot indicate laryngeal sensory neuropathy
  330. Phenotypic Heterogeneity of the Mitochondrial DNA Variant m.13513 G > A
  331. Diagnosing mitochondrial, neurogastrointestinal leukoencephalopathy requires mutations in TYMP1, POLG1, LIG1, or RRM2B
  332. Anatomy and physiology argue against SARS-CoV-2-associated Parsonage–Turner syndrome if the accessory nerve is affected
  333. SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
  334. Pituitary apoplexy is not uncommon in pediatric patients and can be a manifestation of neuro-COVID
  335. Intra-familial phenotypic heterogeneity of m.3243A > G carriers remains elusive as long as heteroplasmy and mtDNA copy numbers are absent
  336. Assessing post‐COVID myopathy by MRI requires large cohorts and comparison with a gold standard
  337. Stroke thrombolysis or not for an intraventricular thrombus
  338. Obstetric involvement in mitochondrial disorders: A review
  339. Rhabdomyolysis or Myositis following a SARS-CoV-2 Vaccination
  340. Before diagnosing a stroke‐like episode, a stroke‐like lesion must be documented on multimodal cerebral MRI
  341. Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid
  342. Before blaming SARS-CoV-2 for venous sinus thrombosis in a septic patient, consider alternative etiologies
  343. Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
  344. Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants
  345. Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
  346. Rule out all differentials before initiating growth hormone treatment in short MELAS patients
  347. SARS-CoV-2 Vaccination Related, Pediatric Guillain-Barre Syndrome Requires the Same Management as in Adults
  348. Rule out differentials before diagnosing SARS-CoV-2 vaccination related Parsonage-Turner syndrome
  349. If SARS-CoV-2 is blamed for causing meningoencephalitis, the virus must be detected in the CSF
  350. Ocular motility disorders after SARS-CoV-2 vaccination require the exclusion of all differential causes
  351. Let's not blame cocaine as a cause of rhabdomyolysis until all other causes have been ruled out
  352. Musculoskeletal complications of COVID-19 can contribute to its morbidity and mortality
  353. Phenotypic expression of the m.3243A > G variant not only depends on heteroplasmy or haplotype
  354. Diagnosing SARS-CoV-2 vaccination-related rhabdomyolysis requires the exclusion of all differential causes
  355. Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant: Correspondence
  356. Promptly and appropriately treat SARS-CoV-2– related Guillain-Barre syndrome in a gravida to improve the outcome
  357. High‐dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes without a beneficial clinical or cerebral tissue effect
  358. Before attributing subdural empyema to SARS-CoV-2—differential causes must be ruled out
  359. Neuropathologic findings in COVID-19 patients should be correlated with clinical neurologic abnormalities
  360. Post‐COVID vaccination Guillain–Barre syndrome
  361. Do seizures in POLG1-related mitochondrial disorder become refractory due to mitochondrion-toxic anti-seizure drugs?
  362. Epileptic nystagmus in MELAS and non-mitochondrial disorders
  363. First tonic-clonic seizure five hours after Ad26.COV2.S vaccination without acute brain lesion but long-term chorea
  364. LHON Plus Due to the Variant m.3460G > A Requires Extensive Investigation and Close Monitoring
  365. Leigh syndrome can manifest with intracranial calcifications and bleedings
  366. Long post-COVID-vaccination syndrome manifesting as temperature-sensitive myalgia and hyper-CKemia
  367. Medical research: Are e-Sports really sports?
  368. Mitochondrial small fiber neuropathy as a novel phenotypic trait of Leigh-like syndrome due to the variant m.10191T>C in MT-ND3
  369. Pseudomonas aeruginosa ventriculitis following pancytopenia due to myelodysplastic syndrome with an excess of blasts type 2
  370. Role of cardiac β1-adrenergic and A1-adenosine receptors in severe arrhythmias related to Parkinson's disease
  371. SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis
  372. Severe thrombocytopenia due to idiopathic myelodysplastic syndrome complicated by spontaneous, fatal intracerebral hemorrhage
  373. Small fiber neuropathy with long-term, multifocal paresthesias after a SARS-CoV-2 vaccination
  374. Standards for the treatment of juvenile, ischemic stroke should not be abandoned for SARS-CoV-2 positives
  375. Stroke seven hours after SARS-CoV-2 vaccination
  376. The amygdala lesioning due to status epilepticus – Changes in mechanisms controlling chloride homeostasis
  377. The pituitary gland in SARS-CoV-2 infections, vaccinations, and post-COVID syndrome
  378. Arterial hypertension in Leigh syndrome due to m.13513G > A is multicausal, requiring an extensive search to identify its pathphysiology
  379. Before Plaque Enhancement Can Predict Stroke Recurrence, Alternative Etiologies Must Be Off the Table
  380. Before blaming SARS-CoV-2 vaccines for thalamic lacunar stroke, alternative etiologies must be ruled out
  381. Characteristics of stroke-like lesions on cerebral imaging
  382. Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”
  383. Differentials of respiratory failure in COVID-19 patients with myasthenia
  384. Discrepancy between clinical presentation and cerebral imaging requires further diagnostic effort
  385. Distal peripheral nerves may be involved in Parsonage Turner syndrome
  386. Generation of Normal Values for Respiratory Muscle Force Requires That the Control Group Be Examined Neurologically
  387. Inflammatory markers as outcome predictors of COVID-19 in pregnant women
  388. Is SARS-CoV-2 vaccination related Guillain-Barré syndrome really different from that due to other causes?
  389. Is insulin resistance truly responsible for post-COVID depression?
  390. Letter to the Editor: Assessing the Effect of Thrombectomy up to 24h After Onset of Stroke Requires Large, Prospective, International Studies
  391. Letter to the Editor: Frequency of Visual Aura in Non-Migraine Headache Strongly Depends on the Underlying Pathophysiology
  392. Letter to the Editor: Nerve Entrapment From a Crush Injury During the Halloween Mass Casualty Accident in Itaewon
  393. Letter to the Editor: RE: Reyes-Ruizet al.: Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I. In Vivo37(2): 933-939, 2023 – SARS-CoV-2-related Encephalitis Does Not Adequately Explain Oral Ulcer...
  394. Long-COVID syndrome requires extensive diagnostic work-up
  395. Neuro-COVID in the young
  396. Progressive multifocal leukoencephalopathy cannot be due to liver cirrhosis alone
  397. Radiomic Models for Diagnosing Juvenile Myoclonic Epilepsy Should Note Its Genetic Heterogeneity
  398. Respiratory insufficiency in Leigh syndrome is multifactorial and requires further investigation in addition to polysomnography
  399. SARS-CoV-2 Infection Control and Burnout Prevention Among Healthcare Workers Require Individual and Public Action
  400. SDHA Variants Can Only Be Classified as Causative Once Their Pathogenicity Has Been Proven
  401. Sudden Death Is More Likely to Result From SARS-COV-2 Infection Than Multiple Sclerosis
  402. Weak evidence for a relation between bipolar disorder and heterozygous
  403. Frequency of new seizures after SARS-CoV-2 infections may depend on the length of follow-up
  404. All differential diagnoses of cerebellar ataxia should be ruled out before SARS‐CoV‐2 is blamed as the cause
  405. SARS-CoV-2-related cardiovascular complications in the tropics
  406. Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2
  407. Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain–Barre syndrome rather than CIDP
  408. Guillain–Barre/Miller–Fisher overlap syndrome or acute, motor and sensory, axonal neuropathy with cranial nerve involvement?
  409. Polyradiculitis Complicating SARS-CoV-2 Vaccinations is not Infrequent
  410. Apply the Hirano or Japanese criteria when diagnosing MELAS
  411. Loss of consciousness due to COVID-19 should not go unexplained, even in an octogenarian
  412. Workup for cerebral involvement in COVID-19 requires cerebral imaging, electroencephalography, and cerebrospinal fluid studies
  413. Ophthalmologic compromise following SARS-CoV-2 vaccinations
  414. Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates
  415. Elucidating the causes of post SARS‐CoV‐2 neuropathy / myopathy requires comprehensive investigations because of the broad spectrum of different etiologies
  416. Prevention of sudden death in Kearns‐Sayre syndrome requires prospective studies
  417. Before blaming the tooth extraction for the TTS, consider alternative triggers
  418. Don’t promise something that is not there
  419. Re: “SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections” by Meidaninikjeh et al
  420. SARS‐CoV‐2 vaccinations can trigger polyradiculitis
  421. Sudden death in m.3243A > G carriers is multicausal and requires extensive work-up
  422. Letter to the Editor: “Impact of autopsy on clarification of the cause of death in pediatric COVID-19 fatalities”
  423. Mitochondrial Dysfunction in Polycystic Ovary Syndrome
  424. Consider SARS-CoV-2 in patients with diarrhoea, vomiting, thrombocytopenia, polyradiculitis, and seizures
  425. Consider affection of respiratory muscles in SARS-CoV-2 related polyradiculitis with coughing but normal inflammatory markers
  426. On “Guillain-Barré Syndrome Related and Unrelated to COVID-19: Clinical Follow-Up in the COVID-19 Era.” Masuccio FG, Tipa V, Invernizzi M, Solaro C. Phys Ther. 2022; 102:pzac049. https://doi.org/10.1093/ptj/pzac049
  427. Pituitary apoplexy in SARS-CoV-2 infected is not necessarily related to the virus
  428. Retinal artery/vein occlusion complicating SARS-CoV-2 vaccinations
  429. Rule out differentials before blaming SARS-CoV-2
  430. Transient tunnel vision and altered consciousness after a single dose of ibuprofen
  431. Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
  432. Post‐COVID myopathy
  433. Multimodal MRI in Leigh syndrome due to m.13513G > A
  434. Consider multisystem inflammatory syndrome in children with kidney failure after SARS-CoV-2 vaccination
  435. Facial Diplegia Complicating Anti-SARS-CoV-2 Vaccinations
  436. Cerebral tuberculoma are commonly accompanied by other imaging abnormalities
  437. Do not miss Bickerstaff encephalitis as a complication of SARS-CoV-2 vaccines
  438. Is there a post-SARS-CoV-2 vaccination dementia?
  439. Major Update 2: Remdesivir for Adults With COVID-19
  440. Consider a cerebellar stroke-like lesion only after adequately ruling out all differential diagnoses
  441. Febrile Seizures in COVID-19 Patients Are Multifactorial
  442. Heterogeneous Manifestation of POLG1 Variants: Heterogeneity of POLG1 Phenotypes
  443. Before blaming a COVID vaccine for cytotoxic lesions of the corpus callosum all other differentials must be ruled out
  444. Letter to the Editor regarding “COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study”
  445. Carriers of POLG1 variants require investigations for multisystem disease and for mtDNA variations
  446. Determining prediction factors of post-neurosurgical thrombosis requires consideration of the entire spectrum of risk factors
  447. Diagnosing Weber syndrome requires compliance with diagnostic criteria and compatibility with cerebral imaging
  448. Neuro-COVID is not at variance between children and adults
  449. No need for brain biopsy in acute disseminated encephalomyelitis after first Sputnik-V jab
  450. The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad
  451. Polyneuropathie
  452. Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site
  453. Rule Out Alternative Causes Before Attributing Acute, Haemorrhagic, Leukoencephalitis (AHLE) to COVID-19
  454. Assessing the anesthetic effectiveness of remimazolam in MELAS patients requires careful investigations
  455. Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
  456. Take children with progressive quadruparesis after SARS-CoV-2 infection seriously
  457. Consider cerebral tuberculosis as differential of SARS-CoV-2-associated acute, haemorrhagic, necrotising encephalitis
  458. Consider alternative causes of thrombo-embolism to SARS-CoV-2 in COVID-19 patients
  459. Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently Ignored [Letter]
  460. Neuromyelitis optica complicating COVID vaccinations
  461. Real world data speak a different language about the outcome of pregnancies undergoing SARS-CoV-2 vaccinations
  462. Secondary mechanisms by which SARS-CoV-2 affects the brain
  463. Neurological disease in pregnant females with COVID ‐19 may not only be attributable to SARS‐CoV ‐2
  464. Wernicke Encephalopathy Mimicking MELAS
  465. Intensification of an Essential Tremor by SARS-CoV-2
  466. De novo altered mental state after SARS-CoV-2 vaccination requires extensive diagnostic work-up
  467. Metformin in m.3243A>G carriers can be both detrimental and beneficial
  468. Parkinson's Disease, Premature Mortality, and Amygdala
  469. The diagnosis of SARS-CoV-2 associated ADEM requires the exclusion of all differential diagnoses
  470. When is the SARS-CoV-2 infection over and what is post-COVID?
  471. Vaccine Adverse Event Reporting System Could Miss or Misinterpret Neurological Side Effects of COVID‐19 Vaccinations
  472. The Apparent Beneficial Effect of L-arginine for Stroke-like Lesions can Be Accidental
  473. Small fiber neuropathy underlying dysautonomia in COVID‐19 and in post‐SARS‐CoV‐2 vaccination and long‐COVID syndromes
  474. SARS-CoV-2 vaccinations complicated by transverse myelitis
  475. Comment on: Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series
  476. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome in children is challenging like in adults
  477. Imaging abnormalities in pediatric neuro-COVID are more diverse than specified
  478. Real-world data about the side effects of SARS-CoV-2 vaccinations can be obtained only from representative samples undergoing comprehensive investigations
  479. Exclude differentials before diagnosing SARS-CoV-2-associated acute haemorrhagic necrotising encephalitis
  480. Comment on ``Long-term results of palpebral fissure transfer with no lower eyelid spacer in chronic progressive external ophthalmoplegia''
  481. Polyradiculitis and encephalomyelitis in the same patient following a SARS-CoV-2 vaccination
  482. Fatigue and Exercise Intolerance as Initial Manifestations of a Nonsyndromic Mitochondrial Disorder Due to the Variant m.3243A>G
  483. Diagnosing SARS-CoV-2 vaccination associated rhombencephalitis requires comprehensive work-up and exclusion of differentials
  484. Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation
  485. SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations
  486. Bone quality in Duchenne muscular dystrophy
  487. Consider alternative causes before allocating acute ischaemic stroke to COVID-19
  488. Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine
  489. Seizure and neuropsychiatric compromise as onset of SARS-CoV-2 associated encephalitis
  490. Takotsubo Rather Than Kounis Syndrome Complicating SARS-CoV-2 Vaccination
  491. Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
  492. Maternally inherited Leigh syndrome due to an MT-ATO6 mutation
  493. Nerve conduction studies support the classification of SARS‐CoV‐2 associated Guillain‐Barre subtypes
  494. Pattern Recognition in Mitochondrial Leukodystrophies is Hampered by the Peculiarities of Mitochondrial Genetics
  495. Exacerbation of diabetic neuropathy can mimic SARS-CoV-2 associated pure dysautonomic Guillain–Barre syndrome
  496. Impaired hearing following SARS-CoV-2 vaccinations
  497. MELAS with multiple stroke‐like episodes due to the variant m.13513G>A in MT‐ND5
  498. The spectrum of neuro‐COVID is broadening
  499. Consider differentials before diagnosing COVID-19 associated polyradiculitis
  500. Anticoagulated de novo atrial flutter complicated by transitory ischemic attack in fatal COVID‐19
  501. Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’
  502. Guillain-Barre syndrome related to SARS-CoV-2 vaccinations
  503. Is pancreatitis actually a phenotypic manifestation of Leigh syndrome?
  504. Ischemic stroke in 455 COVID-19 patients
  505. SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome
  506. Sudden unexpected death in Parkinson's disease: Insights from clinical practice
  507. Sudden unexpected death in epilepsy and abnormal glucose metabolism in the rat insular cortex: A brain within the heart
  508. The diagnosing of pediatric severe acute respiratory syndrome coronavirus 2 associated myocarditis requires validated criteria
  509. The implication of cardio-oncology on Parkinson's disease: answers begin to emerge
  510. Acute Diffusion MRI Findings in Metabolic Encephalopathies are Diverse
  511. Affection of Cranial Nerves in COVID-19 Patients Should Prompt Suspicion of Guillain-Barre Syndrome
  512. Cognitive aspects of MELAS and CARASAL
  513. Comments on “A Case of MELAS With the m.3243A>G Variant of the MT-TL1 Gene Mimicking Acute Intermittent Porphyria”
  514. Comments on “CSF-Confirmed SARS-CoV-2 Acute Encephalitis”: SARS-CoV-2-Associated Encephalitis Is Autoimmune Rather Than Infectious
  515. Consider Transverse Myelitis as a Complication of a SARS-CoV-2 Vaccination
  516. Diagnose Aseptic Meningitis Caused by SARS-CoV-2 Vaccination Only After Ruling Out All Possible Differentials
  517. Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible
  518. Dysphagia, Dehydration, and Premature Mortality in Parkinson Disease
  519. Familial Intracranial Aneurysm Requires Not Only Whole-Exome Sequencing, But Also Mitochondrial DNA Sequencing
  520. Immunodeficiency Should Be Excluded in Patients With Recurrent Viral Meningitis and Breakthrough COVID-19
  521. Letter to the Editor: Finger Extensor Weakness Is Not a Novel Clinical Feature of SARS-CoV-2 Associated Guillain-Barre Syndrome
  522. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome
  523. Letter to the Editor: Propacetamol-Induced Rhabdomyolysis or COVID-Vaccine-Related Inflammatory Myopathy?
  524. Letter to the Editor: Rule Out Alternative Mechanisms Before Attributing Elevated Hemidiaphragm to Parsonage Turner Syndrome and SARS-CoV-2 Vaccination
  525. Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine
  526. Pathophysiological aspects of neuro-COVID
  527. The Broad Spectrum of Neuro-Radiological Abnormalities in Patients Infected with SARS-CoV-2 Supports the Diagnosis of Neuro-COVID-19
  528. The Microbiota in Parkinson’s Disease: Ranking the Risk of Heart Disease
  529. Do Patient/Doctor Benefits from Telephone/Electronic Contacts Exceed Those of Face-To-Face Visits?
  530. Phenotypic heterogeneity of Leigh syndrome due to NDUFA12 variants is multicausal
  531. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia
  532. Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
  533. Guillain-Barre syndrome is a definite complication of SARS-CoV-2
  534. Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases
  535. Broadening the diagnostic approach for SARS‐CoV‐2 associated myopathy and rhabdomyolysis
  536. Apparent onset of COVID-19 after onset of SARS-CoV-2 associated Guillain-Barre syndrome
  537. Before attributing encephalomyelitis to SARS‐CoV‐2 vaccinations thoroughly exclude differentials
  538. SARS-CoV-2-associated Guillain-Barre syndrome is not infrequent
  539. Suspect MELAS early to prevent unnecessary costs and burdens for the affected
  540. SARS-CoV-2 in cardiomyocytes
  541. Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit
  542. Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
  543. Clinico-Genetic Spectrum of POLG1 Mutation Carriers from India
  544. SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: consider differentials
  545. Survival from liver transplantation in mitochondrial disorders not only depends on periprocedural complications but also on the genotype and on mitochondrion‐toxic drugs
  546. Guillain‐Barré syndrome is immunogenic in SARS‐CoV‐2 infected
  547. Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
  548. Post-COVID Guillain–Barre Syndrome: Comparison of Two Reviews
  549. Exclude differentials before attributing post-COVID fatigue to myopathy
  550. Reagibility of intracerebral arteries does not reflect dynamics of a stroke-like lesions
  551. Knowledge about the characteristics of stroke-like lesions is expandable
  552. Cerebro‐Spinal‐Fluid Cytokine Profiles Do Not Reliably Delineate Encephalopathy and Inflammation in Neuro‐COVID
  553. COVID-19 associated cranial nerve neuropathy: A systematic review
  554. SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination Guillain-Barre syndrome
  555. Noncompaction and the novel variant c.425A>T in TPM1
  556. Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
  557. Do Not Replace Personal Patient/Doctor Interactions by Electronic Visits in Myotonic Dystrophy Patients
  558. MELAS can be delineated from CADASIL by genotype and phenotype
  559. SARS-CoV-2 associated rhabdomyolysis in 32 patients
  560. tRNA variants causing Leber’s hereditary optic neuropathy?
  561. SARS-CoV-2 associated Miller-Fisher syndrome or polyneuritis cranialis
  562. Diagnose SARS‐CoV‐2 associated Guillain–Barre syndrome upon appropriate criteria and after exclusion of differentials
  563. Work‐up of MERRF and MELAS fatalities requires autopsy of the brain and revision of intra‐vitam investigations
  564. Spinal cord involvement in LHON requires pathophysiological clarification
  565. Consider differentials before diagnosing SARS‐CoV‐2 associated Guillain–Barre syndrome
  566. Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination
  567. Coronavirus Disease 2019 Can Be Complicated by Immune-encephalopathy Rather Than Encephalitis
  568. Clinical and Pathophysiologic Spectrum of Neuro-COVID
  569. MuSK‐positive myasthenia may be triggered not only by SARS‐CoV‐2
  570. m.3243A>G carriers develop syndromic or non-syndromic multisystem phenotypes over time
  571. Vascular Damage May Mimic Retinitis and Optic Neuritis in COVID-19
  572. Brain and nerves affected before the lungs in COVID‐19
  573. Involvement of the cardiac conduction system in Kearns–Sayre syndrome is progressive
  574. Superficial siderosis due to multiple cavernomas: an uncommon cause of early‐onset dementia
  575. Does SARS-CoV-2 truly cause infectious myopathy?
  576. Prevent Hyperglycemia in MELAS by Measuring HbA1c Values and by Avoiding Triggering Events
  577. The MELAS phenotype may not only be determined by heteroplasmy of causative mtDNA variants
  578. Comment on “Mitochondrial Neurogastrointestinal Encephalomyopathy: Novel Pathogenic Mutation in Thymidine Phosphorylase Gene in a Patient from Cape Verde Islands”
  579. More likely than through head trauma: is LHON triggered by mitochondrion-toxic drugs or oxidative stress
  580. Sequential Stroke-Like Lesions in MELAS are Common and Diagnosable upon Multimodal MRI
  581. Is unilateral facial palsy truly caused by SARS-CoV-2?
  582. Letter to the editor: sudden death in Parkinson´s disease: treating hypertension in the elderly is essential
  583. SARS‐CoV‐2 and myasthenia
  584. Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
  585. Mental compromise in SARS-CoV-2 infected patients is multicausal, organic or inorganic
  586. Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
  587. Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
  588. Multifocal T2-/DWI-hyperintense cerebral lesions in COVID-19 not necessarily imply demyelination
  589. Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review
  590. Extrapulmonary onset manifestations of COVID-19
  591. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
  592. Ischemic Stroke in COVID-19 Patients May Be Incidentally but Not Causally Related to the Infection
  593. Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination
  594. Parkinson-related neuropathy
  595. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
  596. Prevention of Parkinson's disease-related sudden death
  597. Sudden death in a patient with epilepsy and arterial hypertension: time for re-assessment
  598. Sudden death in a rat model of Parkinson's disease
  599. Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
  600. SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
  601. Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy
  602. Energy requirements in m.3243A>G carriers depend on multiple factors
  603. Phenotypic spectrum of variants in the beta-oxidation enoyl-CoA hydratase-1 (ECHS-1) gene
  604. SARS‐CoV‐2 triggered Takotsubo in 38 patients
  605. Cardiac disease in mitochondrial disorders
  606. Heterogeneous phenotypic expression of C1QBP variants is attributable to variable heteroplasmy of secondary mtDNA deletions and mtDNA copy number
  607. Autonomic dysfunction may not be the only cause of SUDEP
  608. SARS‐CoV‐2–associated Guillain‐Barre syndrome in 62 patients
  609. In Reference to Impact of Fiberoptic Endoscopic Evaluation of Swallowing Outcomes and Dysphagia Management in Neurodegenerative Diseases
  610. Are stroke-like lesions in Leber's hereditary optic neuropathy mistaken as MS-like cerebral lesions?
  611. Is the variant m.9176T > C in MT‐ATP6 truly responsibly for Leigh syndrome?
  612. Letter by Finsterer Regarding Article, “COVID-19-Associated Stress (Takotsubo) Cardiomyopathy”
  613. Outcome of endoscopic lipoma resection in myoclonic epilepsy with ragged-red fibers syndrome may depend on the genotype
  614. SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection
  615. Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF
  616. Exclude hereditary and acquired differential disorders before attributing retinoschisis to Kears-Sayre syndrome
  617. Mitochondrial disorder should be considered as a differential of late-onset myasthenia gravis
  618. Uncovering the etiology of ptosis prior to blepharoplasty
  619. Volume loss and altered neuronal composition in the brainstem reticular zone may not cause sudden unexpected death in epilepsy
  620. Prospective studies on the efficacy of rituximab for myasthenia gravis are warranted
  621. Infectious/parainfectious, nonvascular, nonhypoxic central nervous system disease in 48 COVID‐19 patients
  622. Is the spinal cord truly affected in half of the patients with Kearns-Sayre syndrome?
  623. Factors Influencing Central Nervous System Abnormalities in m.11778G>A Carriers
  624. Comment on Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness: Evaluation of Predicting Parameters
  625. Multisystem disease including stroke, epilepsy, dystonia, noncompaction, and kidney agenesis requires genetic work-up
  626. Early white matter changes on diffusion tensor imaging in amyotrophic lateral sclerosis
  627. Primary hypoparathyroidism and multiple neuraxial involvement in mitochondrial disorder due to the variant m.15043G>A in MT-CYB
  628. Secondary manifestations of mitochondrial disorders
  629. The metabolic hypothesis is more likely than the epileptogenic hypothesis to explain stroke-like lesions
  630. COVID‐19 polyradiculitis in 24 patients without SARS‐CoV‐2 in the cerebro‐spinal fluid
  631. Update on the neurology of COVID‐19
  632. Causes of hypogeusia/hyposmia in SARS‐CoV2 infected patients
  633. Cerebellar stroke-like lesions in Leigh syndrome may mimic cerebellar cortical bleeding
  634. Systemic toxicity to betamethasone ointment
  635. Incapacitating, generalised myalgias and muscle stiffness under duloxetine and aripiprazole
  636. Multisystem Myotilinopathy, including Myopathy and Left Ventricular Noncompaction, due to the MYOT Variant c.179C>T
  637. Double Trouble from POLG1 and CLCN1 Variants with Intrafamilial Phenotypic Heterogeneity
  638. Duchenne muscular dystrophy requires treatment also of cardiac, respiratory, cerebral, and orthopedic compromise
  639. Metabolic stroke or stroke-like lesion: Peculiarities of a phenomenon
  640. “Initial deterioration” upon intravenous methyl-prednisolon in myasthenia is multifactorial
  641. Bulbospinal muscular atrophy (Kennedy disease) responsive to immunoglobulins?
  642. Assessing the effect of non-invasive ventilation on cardiac function in Duchenne muscular dystrophy requires prospective studies
  643. Update Review about Metabolic Myopathies
  644. Assessment of the Idebenone Effect on LHON Eyes Requires High-quality Studies
  645. We never speak about sudden unexpected death in Parkinson's disease
  646. Comment on “CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions”
  647. The metabolic hypothesis is more likely than the epileptogenic hypothesis to explain stroke-like lesions
  648. Cerebellar stroke-like lesions in Leigh syndrome due to the variant m.8993T>C in MT-ATP6
  649. Muscle biopsy is not diagnostic for MELAS
  650. Unusual Phenotype and Disease Trajectory in Kearns–Sayre Syndrome
  651. POLG1-related phenotypes are heterogeneous and progressive due to secondary mtDNA maintenance defects
  652. Stroke-like Episodes in m.3243A≥G Carriers Need to Be Monitored by MRI Starting with the Onset of Clinical Manifestations
  653. Letter to the Editor: Comments on “Obesity associated with a novel mitochondrial tRNACys m.5802A>G mutation in a Chinese family”
  654. Comment on: Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibodies
  655. Low heteroplasmy rates in clinically affected m.3243A > G carriers not necessarily explain the phenotype
  656. Pathogenicity of the variant m.13376 T > C in ND5 remains unproven
  657. Takotsubo syndrome in Duchenne muscular dystrophy may be triggered by epilepsy
  658. Detection of compound heterozygous variants in LPIN1 does not necessarily imply pathogenicity in a patient with rhabdomyolysis
  659. Alcohol and sudden unexpected death in epilepsy: do not pop the cork
  660. Left Ventricular Thrombi and Embolic Events in Takotsubo Syndrome despite Therapeutic Anticoagulation
  661. Rare Phenotypic Manifestations of MELAS
  662. The Leigh phenotype resulting from C12orf65 variants
  663. The mitochondrial calcium uniporter: a new therapeutic target for Parkinson's disease-related cardiac dysfunctions?
  664. MELAS Missed for Years: Stroke-Like Lesions Are No Indication for Brain Biopsy
  665. The Spectrum of Neuromuscular Disorders Admitted to a Pediatric Intensive Care Unit Is Broader Than Anticipated
  666. Viability of diffusion tensor imaging for assessing retro-chiasmatic involvement in Kearns-Sayre syndrome remains elusive
  667. Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion
  668. Multisystem mitochondrial disorder is more prevalent than BGC1 variants in patients with Fahr's syndrome
  669. Only pathogenic variants in protein-coding mtDNA genes cause Leigh syndrome
  670. Stroke-like episodes in OPA1 carriers require comprehensive work-up and therapeutic considerations
  671. Neuropathy due to impaired axonal transport of non-fragmented mitochondria in MYH14 mutation carriers
  672. NEMMLAS Due to Biallelic WARS2 Variants
  673. Central nervous system abnormalities in spinal and bulbar muscular atrophy (Kennedy’s disease)
  674. Cerebral imaging in adult mitochondrial disorders
  675. Elucidation of the genetic background in familial multiple sclerosis requires genetic work-up
  676. Comment on: Sideroblastic anemia associated with multisystem mitochondrial disorders: The phenotypic spectrum of PUS1 and COX10 variants and mtDNA deletions needs to be prospectively assessed
  677. Extensive clinical and genetic workup is worthwhile in patients with Leigh-like syndrome due to the TSFM variant c.547G>A
  678. Ketogenic diet in ATAD3A mutation carriers may not improve cerebellar atrophy but some clinical features [Letter]
  679. Genetic work-up of hereditary spastic paraplegias is crucial for classifying these disorders
  680. Comment on “Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene”
  681. Noncompaction and Takotsubo Syndrome in a Neuromuscular Disorder
  682. Barth syndrome: mechanisms and management
  683. Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C
  684. Doping May Be Responsible for De Novo Mitochondrial Disorder
  685. Before attributing CPEO and ptosis to the variant m.14819T>G its pathogenicity needs to be established
  686. Whole exome should be preferred over Sanger sequencing in suspected mitochondrial myopathy
  687. Comment on APLAR Grand Round: Phenotypes of single mtDNA deletions may unequivocally suggest mitochondrial disease
  688. Diagnostic and therapeutic aspects of Leigh syndrome due to the variant m.10197G>A
  689. Mitochondrial metabolic stroke: Phenotype and genetics of stroke-like episodes
  690. Early-age Ndufs4 knockout mice are an inappropriate animal model of Leigh syndrome
  691. Maternal transmission of CNTN6 copy number variation suggests mitochondrial disorder
  692. Methyl-DOPA causing reversible peripheral facial palsy
  693. Antiepileptics and NO-precursors may be beneficial for stroke-like episodes
  694. Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy
  695. Survival and outcome in MELAS not only depends on onset and disease duration
  696. PTCD3 mutations cause Leigh-like rather than Leigh syndrome
  697. How Do Depressive Mood or Antidepressants Acutely Increase Serum Catecholamines?
  698. Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
  699. ADVERSE REACTION TO ANESTHESIA IN A M.8993T>C CARRIER WITH LEIGH SYNDROME
  700. Genetic Data Are a Prerequisite for Interpreting Clinical and Muscle Biopsy Findings in MELAS
  701. Mitochondrial Ophthalmoplegia Is Not Only due to mtDNA Deletions
  702. Neurological Perspectives of Neurogenic Pulmonary Edema
  703. Peculiarities of stroke-like lesions on MRI
  704. Silencing of FOXRED1 in C57b1/6 mice does not generate an appropriate animal model of Leigh syndrome
  705. Insular cortex lesions are not the only culprit in Takotsubo syndrome
  706. Hereditary transthyretin-related amyloidosis
  707. Patients with MELAS not only require treatment of stroke-like episodes but a comprehensive individual and family management
  708. Liability of sepsis is hardly determined by the COXI variant m.6459T>C
  709. Phenytoin‐induced choreoathetosis after serial seizures due to traumatic brain injury and chronic alcoholism
  710. Tinnitus is multicausal and may not only be related to DNA variants
  711. The Genetic Cause of Kearns-Sayre Syndrome Determines Counselling and Outcome of These Patients
  712. Infantile-onset deafness in m.7445A>G carriers may be multicausal
  713. Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T
  714. Mitochondrial ataxia is genetically and phenotypically heterogeneous
  715. Retinal involvement in m.3243A>G carriers
  716. Neuropathy of peripheral nerves in Leber's hereditary optic neuropathy
  717. Aortic root ectasia as a phenotypic feature of a mitochondrial disorder
  718. Respiratory insufficiency from myasthenia gravis and polymyositis due to malignant thymoma triggering Takotsubo syndrome
  719. MELAS can be psychiatric and neurological
  720. Muscle, cardiac, and cerebral manifestations in female carriers of dystrophin variants
  721. Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”
  722. Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
  723. Phenotypic heterogeneity of POMT2 gene variants
  724. Kearns-Sayre syndrome in the absence of a mtDNA deletion?
  725. Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
  726. Phenotypic spectrum of POLG1 mutations
  727. Can MR spectroscopy and muscle biopsy findings be correlated with MELAS and CPEO?
  728. Takotsubo in amyotrophic lateral sclerosis
  729. Is the Takotsubo syndrome a brain-heart or multiorgan disorder?
  730. Psychological morbidity in Leber’s hereditary optic neuropathy depends on phenotypic, social, economic, and genetic factors
  731. Transient global amnesia: The cerebral Takotsubo?
  732. Multisystem Disease, Including Eosinophilia and Progressive Hyper-Creatine-Kinase-emia over 10 Years, Suggests Mitochondrial Disorder
  733. NDUFS4‐related Leigh syndrome in Hutterites
  734. Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease
  735. A MELAS phenotype is not necessarily MELAS
  736. Leber’s hereditary optic neuropathy is multiorgan not mono-organ
  737. Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
  738. Ophthalmologic involvement in mitochondrial disorders
  739. Metabolic myopathy facilitating the development of Takotsubo syndrome
  740. Familial accumulation of sudden cardiac deaths and the LMNA variant c.868G > A (p.Glu290Lys)
  741. Accuracy of clinical and electrophysiological criteria for diagnosing amyotrophic lateral sclerosis
  742. Affection of the frontal lobe in Leigh syndrome due to the m.8993 T > G mutation
  743. Familial noncompaction on cardiac computed tomography
  744. In the heart of MELAS syndrome
  745. Allergy to transdermal fentanyl resulting in Staphylococcus aureus sepsis and fatal endocarditis with myocardial rupture
  746. Arrhythmias in MELAS syndrome
  747. Concerns about idarucizumab for dabigatran reversal
  748. Double trouble progressive external ophthalmoplegia and Huntington's disease
  749. Heterogeneous pathogenesis of mitochondrial neuropathy
  750. Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
  751. Myotone Dystrophien: Klinik, Pathogenese, Diagnostik und Therapie
  752. Mitochondrial disorder caused Charles Darwin's cyclic vomiting syndrome
  753. Lymphangiopathy in neurofibromatosis 1 manifesting with chylothorax, pericardial effusion, and leg edema